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ARTICLE
Modulation of actin polymerization affects
nucleocytoplasmic transport in multiple forms of
amyotrophic lateral sclerosis
Anthony Giampetruzzi1,4, Eric W. Danielson1,4, Valentina Gumina2, Maryangel Jeon1, Sivakumar Boopathy1,
Robert H. Brown1, Antonia Ratti2,3, John E. Landers1,5 & Claudia Fallini1,5
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of unknown etiology.
Although defects in nucleocytoplasmic transport (NCT) may be central to the pathogenesis
of ALS and other neurodegenerative diseases, the molecular mechanisms modulating the
nuclear pore function are still largely unknown. Here we show that genetic and pharmaco-
logical modulation of actin polymerization disrupts nuclear pore integrity, nuclear import, and
downstream pathways such as mRNA post-transcriptional regulation. Importantly, we
demonstrate that modulation of actin homeostasis can rescue nuclear pore instability and
dysfunction caused by mutant PFN1 as well as by C9ORF72 repeat expansion, the most
common mutation in ALS patients. Collectively, our data link NCT defects to ALS-associated
cellular pathology and propose the regulation of actin homeostasis as a novel therapeutic
strategy for ALS and other neurodegenerative diseases.
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1 Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA. 2 Istituto Auxologico Italiano, IRCCS, Department of
Neurology – Stroke Unit and Laboratory of Neuroscience, Milan, Italy. 3 Department of Medical Biotechnology and Translational Medicine, Università degli
Studi di Milano, Milan, Italy. 4These authors contributed equally: Anthony Giampetruzzi, Eric W. Danielson. 5These authors jointly supervised this work: John
E. Landers, Claudia Fallini. Correspondence and requests for materials should be addressed to C.F. (email: cfallini@uri.edu)
NATURE COMMUNICATIONS |         (2019) 10:3827 | https://doi.org/10.1038/s41467-019-11837-y | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Amyotrophic lateral sclerosis (ALS) is a neurodegenerativedisease of unknown etiology characterized by progressiveloss of motor neurons (MNs). Most ALS cases are
sporadic and ~10% are familial, yet the two classes are clinically
indistinguishable suggesting that similar pathways may be
responsible for the MN degeneration. Defects in nucleocyto-
plasmic transport (NCT) have been observed in both cellular and
in vivo models of ALS and reinforced by pathological evidence in
familial and sporadic ALS patients1–7. Nuclear deficiency of
RNA-binding proteins (RBPs) such as TDP-43 and FUS is a
pathological hallmark of the disease8, strongly supporting a link
between NCT and ALS pathogenesis.
NCT is a tightly regulated process that actively controls the
separation and exchange between cytoplasmic and nuclear pro-
teins and RNAs. It is centered on the function of the nuclear pore
complex (NPC), a multiprotein complex spanning the whole
nuclear envelope and comprised of about 30 different nucleo-
porins9. Other key players controlling NCT are the small GTPase
Ran, its GTPase-activating protein RanGAP1, and the carrier
proteins importins and exportins. The cellular distribution of
these factors confers directionality to the transport10, while the
structural integrity and density of the NPCs across the nuclear
envelope modulate the efficiency of the NCT. Interestingly, some
nucleoporins are the longest-lived proteins in the cell, and they
are never or very slowly replaced once the NPC is formed in post-
mitotic neurons11,12.
Toxic insults such as oxidative stress and protein aggregation
have been shown to negatively impact NCT13,14. Many mutant
ALS-linked proteins show an increased tendency to aggregate,
including SOD1, TDP-43, FUS, and Profilin1 (PFN1). PFN1 is a
small actin-binding protein that positively regulates actin poly-
merization in a formin-dependent manner15. Several mutations in
PFN1 have been identified in ALS patients (C71G, M114T,
G118V, A20T, T109M, Q139L, E117G), representing less than 1%
of all familial cases16,17. Nonetheless, mutations in PFN1 and
other cytoskeletal-related proteins such as TUBA4A and KIF5A
suggest that defects to the cytoskeletal structure and/or function
may play an important role in triggering neurodegeneration18–20.
ALS-linked mutations in PFN1 render the protein unstable and
aggregation prone, leading to the formation of cytoplasmic
inclusions16,21. The ability of mutant PFN1 to associate with -actin
is also impaired, and mutant PFN1 MNs show morphological
abnormalities, such as smaller growth cones and shorter axons16.
The C71G and G118V mutations have consistently shown more
severe phenotypes compared to other mutations in in vitro assays,
and transgenic animals expressing these mutations develop ALS-
like disease and die prematurely22,23. However, the molecular
mechanisms leading to MN degeneration due to mutations in
PFN1 are still unknown. Here, we demonstrate that alterations
to the actin cytoskeleton caused by mutant PFN1 disrupt the NCT
and consequently the normal function of ALS-relevant RBPs,
leading to MN dysfunction. Interestingly, modulating actin
homeostasis was able to rescue the NCT defects caused by
not only mutant PFN1 but also C9ORF72 repeat expansion,
suggesting this pathway could represent a novel therapeutic
strategy for ALS.
Results
Mutations in PFN1 impair nucleocytoplasmic transport. To
investigate whether mutant PFN1 toxicity is associated with
nucleocytoplasmic transport (NCT) defects, we examined its
effects on the distribution of essential factors controlling this
process. Wild type (WT) or mutant (i.e., C71G and G118V) V5-
tagged PFN1 were transfected in primary motor neurons (MNs)
for 4 days. Similar cellular distribution and expression was
observed for all constructs. No effect on cell survival was evident
at this time point due to the expression of mutant PFN1 (Sup-
plementary Fig. 1). To visualize the localization and composition
of the nuclear pore complex (NPC) along the nuclear envelope
(NE), we stained MNs expressing WT or mutant PFN1 with
antibodies recognizing (1) nucleoporins of the FG-Nup family
(i.e., Nup62, Nup153, Nup214, and Nup358; mAb41424), (2)
Nup358/RanBP2, and (3) the transmembrane Nup POM121,
given their essential role in regulating NPC structure and func-
tion25–27. In PFN1WT cells, all nucleoporins examined displayed a
strong, punctate staining around the nucleus, as identified by
DAPI staining, similar to mock-transfected controls (Supple-
mentary Fig. 2). In contrast, a significantly higher percentage of
mutant PFN1 MNs showed reduced or absent staining at the NE
(Fig. 1a, b, Supplementary Fig. 3). Consistent with its known
association to the NPC via RanBP2, RanGAP1 localized along the
NE in both mock-transfected controls and PFN1WT cells, while
its staining pattern was partially or completely disrupted in
mutant PFN1 MNs (Fig. 1c, Supplementary Fig. 2). The presence
of mutant PFN1 led the transport factor Ran to be abnormally
redistributed to the cytoplasm, in contrast to its mostly nuclear
localization in PFN1WT cells (Fig. 1d, Supplementary Fig. 2). This
effect was more pronounced in cells containing visible inclusions,
although MNs with no obvious aggregates still had Ran cyto-
plasm:nucleus (C:N) ratios significantly higher than PFN1WT
values. No co-aggregation of any of the tested proteins with
PFN1C71G-positive inclusions was observed by immuno-
fluorescence, detected by V5-staining (Fig. 1e), solubility assay (Fig.
1f), or co-immunoprecipitation (Fig. 1g). In addition, no changes
in RanGAP1 SUMOylation, which is necessary for its association
with the NPC28, were detected (Fig. 1h). Similarly, no difference in
the overall levels of the tested nucleoporins was observed in all
conditions, while a slight reduction in Ran levels was present in
PFN1C71G MNs (Supplementary Fig. 4). We did not observe
changes to the localization of karyopherins Exportin 1 (XPO1)
and Importin-β, though a small reduction in XPO1 levels was
detected in PFN1C71G MNs (Supplementary Fig. 5). In all, these
data suggest that in the presence of mutant PFN1, NPCs are
either reduced in number or structurally compromised because of
the lack of essential nucleoporins, and additional key players in
NCT are abnormally distributed. Future studies will be required
to directly observe and characterize such structural defects.
Mutant PFN1 alters the structure of the nuclear membrane.
Since the NPC is tightly connected with the nucleoskeleton, we
further investigated the effect of mutant PFN1 on the nuclear
structure using transmitted electron microscopy. Similarly to
what was observed in cells expressing TDP-43 C-terminal frag-
ment1, we found that the expression of either V5-tagged or GFP-
tagged PFN1C71G in Neuro2a cells led to severe defects in the
structure of the nucleus, with the presence of frequent folds,
invaginations, and protrusions that were never observed in
untransfected or PFN1WT-transfected N2a cells (Fig. 2a). This
observation was confirmed by immunofluorescence analysis of
Lamin A/C, one of several proteins constituting the nuclear
lamina such as Lamin B1 and B2, emerin, Lamin B receptor,
Nurim, MAN1, LAP1A-C, and LAP229. This analysis showed
non-uniform and irregular staining in MNs expressing mutant
PFN1 (Fig. 2b). Of note, we noticed that expression of PFN1WT
itself caused a slight increase in the percentage of cells with
abnormal lamin staining compared to mock-transfected cells
(Supplementary Fig. 2). We also found that cells with abnormal
Lamin A/C staining were characterized by reduced nuclear levels
of the protein (Fig. 2c) but no increase in cytoplasmic levels
(Supplementary Fig. S4), suggesting that Lamin A/C may be
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targeted for degradation as a consequence of its altered
localization.
NPC integrity is compromised in patient-derived lympho-
blasts. To verify that the effect of mutant PFN1 on the nuclear
pore occurs also in human ALS patient cells, we performed
immunofluorescence assays in immortalized lymphoblast cells
derived from 3 controls and 3 patients carrying either the C71G
or G118V PFN1 mutation16. Analyses of the localization and
staining pattern of FG-Nups, RanGAP1, Ran, and Lamin A/C
were performed on all lymphoblast lines. We found that the
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Fig. 1 Mutant PFN1 alters the composition and density of NPCs. a, c Antibody against FG-Nups (a, green; mAb414), POM121 (b, green), and RanGAP1
(c, green) localization to the NE (identified based on DAPI staining) is altered in a higher percentage of MNs expressing V5-tagged mutant PFN1 vs PFN1WT
control (red). d Ran (green) cytoplasm to nucleus (C:N) ratio is increased in MNs expressing V5-WT or mutant PFN1 (red), regardless of the presence of
aggregates (agg), indicating possible functional defects in the segregation of cytoplasmic and nuclear proteins. e PFN1C71G -positive cytoplasmic inclusions
(red) as described in Wu et al. (2011) in MNs are not positive for FG-Nups, POM121, RanGAP1, or Ran (green), suggesting no co-aggregation under these
conditions. f No difference in the solubility of Ran (middle panel) or RanGAP1 (top panel) caused by the expression of PFN1 mutants when assayed in
HEK293 cells using detergent-based cellular fractionation. Triton X-100 (2%) and urea (8M) were used to extract the soluble and insoluble fraction,
respectively. g Representative blot of a co-immunoprecipitation (co-IP) assay between V5-tagged WT or mutant PFN1 and RanGAP1 (top panel) or Ran
(middle panel). No bands were detected in the IP pellet, suggesting lack of interaction. h Representative western blot and quantification showing
unchanged levels of SUMO1-modified RanGAP1 in the presence of mutant PFN1. Both antibodies against SUMO1 (top panel) and RanGAP1 (second panel)
detect a band ~80 KDa corresponding to SUMOylated RanGAP1. V5 antibody (bottom panel) shows the expression of the V5-tagged PFN1 protein, while β-
tubulin was used as a loading control. Bars are mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001. N= 3–5 independent experiments (a–c), 76–103 cells from
6 independent experiments (d), 4 independent experiments (h). DAPI (blue) was used to detect the nucleus and assess cell health. Scale bars: 10 µm. See
also Supplementary Figs. 1–5, and Supplementary Table 1 for details on statistics
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percentage of cells with abnormal staining of Lamin A/C and
RanGAP1 was significantly increased in all three lines endogen-
ously expressing mutant PFN1 (Fig. 3), while FG-Nups—recog-
nized by the mAb414 antibody (AbCam)—showed a significant
change only in the G118V line. Further, we found that the
nucleocytoplasmic localization of Ran was significantly altered in
the C71G lines. No changes in the overall levels of all proteins
tested, including endogenous PFN1, were detected (Supplemen-
tary Fig. 6). To test whether the changes in Ran localization were
caused by alteration to the integrity of the nuclear membrane, we
assessed the ability of a large inert molecule (i.e., 70 KDa-Dex-
tran) to bypass the NPC and accumulate in the nucleus. No
increase in the presence of leaky nuclei was observed suggesting
that disruption to nuclear membrane integrity is not an early
event caused by mutant PFN1, at least under these experimental
conditions (Supplementary Fig. 6). Together, these data support
the hypothesis that endogenous levels of mutant PFN1 directly
affects the nuclear pore structure/stability in ALS patient cells,
possibly leading to neuronal degeneration.
Nuclear import is greatly reduced by mutant PFN1. To further
explore the functional consequences of the structural defects
caused by mutant PFN1 on the NCT, we measured the rate of
nuclear import by live cell imaging using a NLS-NES-mCherry
(Shuttling (S)-mCherry) reporter30. Cortical neurons were co-
transfected with GFP or GFP-tagged PFN1 and S-mCherry. S-
mCherry localized mainly to the cytoplasm in all conditions due
to the stronger effect of the nuclear export signal (NES) compared
to the nuclear localization signal (NLS) (Fig. 4e). Thirty-six hours
after transfection, cells were treated with Leptomycin B (LMB)—a
selective inhibitor of Exportin 1—to inhibit nuclear export,
leading to a measurable time-dependent accumulation of the
reporter in the nucleus. We found that the expression of mutant
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Fig. 2 The nuclear membrane integrity is compromised by mutant PFN1. a Transmission electron microscopy shows the presence of protrusions and folds
(arrows) in Neuro2a cells expressing V5- or GFP-tagged PFN1C71G compared to untransfected (Untr.) or PFN1WT cells, similar to what observed in the
presence of TDP-43 C-terminal fragment (CTF). Arrows point to anomalous membrane structures in the nucleus. Aggregates (asterisks) are visible as dark
amorphous structures in the cytoplasm. b Lamin A/C (green) distribution at the NE is altered in a higher percentage of mutant PFN1 MNs. c Overall nuclear
levels of Lamin A/C also appear slightly reduced in cells with abnormal staining. Boxes indicate areas enlarged in insets. DAPI (blue) was used to detect the
nucleus and assess cell health. Scale bars: 2 µm in (a), 10 µm in (b). Bars are mean ± SEM; *p < 0.05, **p < 0.01. N= 5 independent experiments (b) and
14–47 cells from 5 independent experiments (c). See also Supplementary Fig. 2 and Supplementary Table 1 for details on statistics
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PFN1 led to a significant reduction in import rates compared to
both GFP- and PFN1WT-transfected cells (Fig. 4a–c), and an
increase in the percentage of non-responder cells (39% in C71G
vs 6% WT) (Fig. 4d). Expression of PFN1WT also reduced import
rates compared to the GFP control, but to a lesser degree com-
pared to mutant PFN1. In all, these data suggest that mutant
PFN1’s ability to affect nuclear stability, by altering the compo-
sition and/or the number of functional NPCs, leads to severe
nuclear import defects.
Mutant PFN1 alters mRNA post-transcriptional regulation.
One of the main classes of proteins that shuttle between the
nucleus and the cytoplasm are RBPs which control the post-
transcriptional fate of mRNAs. Thus, we investigated the impact
of mutant PFN1-dependent disturbance to NCT on the dis-
tribution of RBPs by quantifying the nuclear and cytoplasmic
levels of the mostly nuclear proteins TDP-43 and FUS, and of the
mostly cytoplasmic proteins SMN and FMRP. As expected, the
majority of TDP-43 and FUS was nuclear in WT-expressing
MNs, while mutant PFN1 expression led to a shift in the C:N
ratio of both proteins (Fig. 5a, b). Again, no effect of PFN1WT
expression was observed on the localization of the proteins
compared to untransfected controls (Supplementary Fig. 7). On
the contrary, there was no quantifiable changes in the distribution
of the mostly cytoplasmic FMRP and SMN proteins, although we
observed fewer SMN-positive nuclear gems (Supplementary Fig. 8).
We also observed a significant reduction in TDP-43 localization
to the proximal motor axon (Supplementary Fig. 7) and an
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Fig. 3 NPC composition is altered in patient-derived lymphoblast cells. Immunofluorescence analyses and quantification of the localization of FG-Nups
(a, b; red), Ran C:N ratio (c, d; green), Lamin A/C (e, f; red) and RanGAP1 (e, g; black) reveal alterations to the NPC composition in lymphoblast cells
derived from 3 ALS patients carrying PFN1 C71G or G118V mutation compared to 3 control lines. Quantifications show an increase in the percentage of cells
with disrupted Lamin A/C and RanGAP1 staining for all lines, while FG-Nups and Ran were significantly altered only in the G118V or C71G mutant lines,
respectively. Bars are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. non-significant. N= 4 independent experiments (b, f, g); 45–48 cells from 3
independent experiments (c). DAPI (blue) was used to detect the nucleus and assess cell health. Scale bars: 10 µm. See also Supplementary Fig. 6 and
Supplementary Table 1 for details on statistics
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increase in TDP-43 aggregation, possibly mediated by TDP-43’s
illegitimate interaction with mutant PFN1 (Supplementary Fig.
9). Together, these data suggest that mutant PFN1 perturbs the
distribution of ALS-relevant nuclear RBPs by destabilizing the
NPC and impairing nuclear import. To investigate the down-
stream consequences of PFN1-mediated mislocalization of such
RBPs, we focused as a proof of principle on TDP-43’s well-
studied regulatory activity on the axonal localization of the neu-
rofilament L (Nefl) mRNA31 and on the splicing of POLDIP3 pre-
mRNA32. Quantitative fluorescence in situ hybridization was
performed in MNs expressing either GFP or GFP-tagged WT or
C71G PFN1 (Fig. 5c, Supplementary Fig. 10). While no difference
in the somatic levels of the Nefl mRNA was detected, its axonal
levels were severely reduced in C71G-expressing MNs. Immor-
talized lymphoblast cell lines derived from 4 controls and 3
patients carrying PFN1 mutations16 were used to evaluate the
abundance of two alternatively spliced POLDIP3 variants—S1
and S2—by RT-PCR (Fig. 5d). In all ALS lines, the relative levels
of isoform S2 were significantly increased over control cells.
Together these data suggest a loss of function for TDP-43 in
mutant PFN1 cells, possibly due to its nucleocytoplasmic
redistribution.
Nuclear export inhibitor improves ALS relevant phenotypes.
To assess the causality between NCT disturbance, RBP mis-
localization, and MN pathology, we investigated the potential of
nuclear export inhibitor KPT-276, a well-established selective
inhibitor of XPO16,33,34, to rescue PFN1-dependent defects. First,
PFN1WT or PFN1C71G expressing MNs were treated with 50 nM
KPT-276 or DMSO for 6 h prior to fixation and the C:N ratio of
TDP-43 was determined. KPT-276 treatment was able to fully
rescue TDP-43 cytoplasmic mislocalization (Fig. 6a), confirming
successful inhibition of nuclear export. Next, we sought to
determine the potential of KPT-276 treatment to rescue axonal
outgrowth defects previously described in mutant PFN1 MNs16.
MNs expressing mutant PFN1 and treated with vehicle alone had
significantly shorter axons compared to PFN1WT cells, while
KPT-276 treatment fully rescued the defect (Fig. 6b). Similar
rescue was observed by measuring the rate of axon growth by live
cell imaging over the course of 1 h (Fig. 6c, Supplementary Movie
1). Together, these data support a direct link between NCT,
mRNA regulation, and PFN1-dependent ALS cellular defects.
Modulation of actin polymerization modifies NCT. PFN1’s
main cellular function is to promote actin polymerization by
facilitating formin-based actin nucleation and elongation, a
function impaired by the presence of ALS-linked mutations16,21.
Thus, we hypothesized that PFN1-mediated disruption of the
actin network could directly interfere with protein nuclear shut-
tling by affecting nuclear stability. Supporting this hypothesis, we
observed a severe mislocalization of RanGAP1, FG-Nups, and
Ran in MNs treated with the actin depolymerizing drug
Latrunculin A (LatA) (Fig. 7a, b and Supplementary Fig. 11),
resembling the phenotypes identified in mutant PFN1 MNs.
LatA-treated MNs also had smaller nuclei with condensed DNA,
suggesting the disruption of the actin cytoskeleton interfered with
normal nuclear morphology. No increased cell death or apoptosis
was observed under these treatment conditions (Supplementary
Fig. 11). To further this observation, we used a complementary
approach and attempted to rescue NPC defects in PFN1C71G
MNs by positively modulating actin polymerization. To this end,
we took advantage of the ability of formins to promote actin
polymerization, albeit at a slower rate, even in the absence of
functional PFN135. Overexpression of a constitutively active form
of the formin mDia1 (FH1-FH2 domains), here on called mDia1,
in mutant PFN1 MNs was indeed able to restore normal actin
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homeostasis (Supplementary Fig. 12), without changing the
aggregation propensity of PFN1C71G. Importantly, while mutant
PFN1 MNs expressing GFP alone had significantly higher fre-
quency of disrupted RanGAP1 staining, as previously observed
(see Fig. 1), the expression of GFP-mDia1 fully rescued the defect
(Fig. 7c). Similarly, GFP-mDia1 expression was able to rescue
TDP-43 mislocalization (Fig. 7d) in mutant PFN1 MNs. As a
parallel approach, we induced actin polymerization using the
small molecule Intramimic-01 (IMM01). This is a specific acti-
vator of formin function that acts by binding to formin and
preventing its autoinhibition36. Treatment of primary MNs with
low concentrations of IMM01 (i.e., 0.1 µM) for 24 h led to the
rescue of FG-Nups defective localization at the nuclear envelope,
as well as of the Ran gradient (Fig. 7e, f). No induction of
apoptosis was detected under these conditions (Supplementary
Fig. 11). Importantly, we found that cytoskeletal remodeling
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induced by IMM01 treatment was also able to rescue the defects
in the axonal localization for the Nefl mRNA (Fig. 7g).
To assess whether actin modulation could also rescue the
function of the nuclear pore, we again measured import dynamics
of S-mCherry in the presence of mDia1 overexpression. A
significant improvement of the import dynamics was observed in
PFN1C71G neurons following mDia1 expression (Fig. 8), suggest-
ing that changes in actin homeostasis can influence the stability of
the NPC and/or NE, affecting protein shuttling. Together, these
data support the existence of a direct link between actin
polymerization, NCT, and mRNA post-transcriptional regulation,
and suggest that these pathways could be central to the onset and/
or progression of the degenerative process in PFN1-linked ALS.
Modulation of actin rescues NCT defects in C9ORF72-ALS.
Next, we sought to investigate whether modulating the actin
cytoskeleton could be beneficial in other forms of ALS char-
acterized by defects to the nuclear pore function, such as those
caused by a repeat expansion in C9ORF72 gene. Thus, we
transfected MNs with a synthetic construct expressing 80
GGGGCC repeats (G4C2)80, that had been previously shown to
induce the presence of RNA foci and dipeptide formation37. The
expression of this construct did not result in any obvious dif-
ference in F-actin levels at the growth cone under our experi-
mental conditions (Supplementary Fig. 13). However, impaired
actin dynamics due to decreased functional cofilin were pre-
viously described in primary MNs and patient-derived cells and
tissues harboring a G4C2 repeat expansion in the C9ORF72
locus38. As anticipated, expression of (G4C2)80 repeats in MNs
led to the loss of RanGAP1 localization to the NE with no change
to its overall levels (Fig. 9a and Supplementary Fig. 13)6. Inter-
estingly, overexpression of the constitutively active form of
mDia1 fully rescued the phenotype. To investigate whether these
effects would occur also in a more relevant disease model such as
ALS patient-derived cells, we treated fibroblasts obtained from 3
patients carrying the C9ORF72 repeat expansion and 3 healthy
controls with the formin activator IMM01. We found that a
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higher percentage of the C9-ALS fibroblasts had disrupted or
abnormal staining for both proteins (Fig. 9b), as previously
reported1,2,6. Similar to what was observed with mDia1 over-
expression, IMM01 treatment was able to rescue defects in the
localization of RanGAP1 and FG-Nups, without changes to the
propensity of the cell to form C9ORF72-positive nuclear foci
(Supplementary Fig. 14). Notably, mDia1 expression was also able
to rescue functional import defects in cortical neurons expressing
(G4C2)80 repeats as detected by S-mCherry dynamics (Fig. 9c–e).
Together, these results suggest that modulation of actin home-
ostasis directly modifies the stability of the NPC and/or NE,
protecting it from disruption caused by ALS-associated gene
mutations.
Discussion
ALS is a heterogeneous disease and mutations in a wide array of
genes are associated with ALS pathogenesis20. Although a com-
mon mechanism linking these different gene mutations may not
be immediately apparent, recent findings from several groups
point at defects in NCT as central to ALS pathology39. Here, we
explore the hypothesis that alterations in cytoskeletal stability
caused by ALS-associated mutations in the actin-binding protein
PFN1 would similarly impact the function of the NPC.
Our immunofluorescence data in primary MNs show that
mutant PFN1 leads to a severe impairment of the NPC structure
and/or number, marked by the loss of nucleoporins from the
nuclear envelope, as well as of its function, as indicated by the
dissolution of the nucleocytoplasmic gradient of Ran, reduced
import rates, and cytosolic mislocalization of nuclear RBPs TDP-
43 and FUS. No changes in the distribution of cytoplasmic
shuttling proteins (i.e., SMN, FMRP, S-mCherry, and PFN1 itself)
were detected, suggesting that mutant PFN1 may have a stronger
effect on nuclear import versus export. The presence of PFN1
aggregates correlated with the severity of the phenotypes observed
but did not directly cause these defects. Indeed, while the more
aggregation prone PFN1C71G mutant led to more severe pheno-
types compared to PFN1G118V, the same defects were observed in
both lines and in the absence of visible inclusion. Importantly,
similar defects to the NPC were also observed in patient-derived
lymphoblast cells, which we have previously shown do not con-
tain any PFN1 positive inclusions16. Lymphoblast cells are
actively dividing and thus reassembling the nuclear envelope and
refreshing the pool of nuclear pores at every cell division, which
could explain why the observed phenotypes were more subtle
compared to post-mitotic neurons. However, we cannot fully
exclude a dose-dependent effect of mutant PFN1 expression on
the mislocalization of these nucleoporins. Regardless, our data
support the hypothesis that mutant PFN1 expression causes
alteration to the nuclear pore possibly leading to neuronal
degeneration.
To investigate how mutant PFN1 disrupts the NCT, we tested
whether it directly affected RanGAP1 protein levels or its asso-
ciation with the nuclear pore, as suggested in flies where loss of
function of PFN1 ortholog Chic was associated with selective
RanGAP1 irregular localization to the NE40. However, we did not
detect any change in RanGAP1 levels or SUMOylation, which is
necessary for its binding to the NPC. Next, we investigated
whether PFN1 aggregation could sequester NCT factors, thus
causing impairment in nuclear shuttling as shown for synthetic
amyloid aggregates and TDP-431,13. Again, we were not able to
detect increased insolubility or co-aggregation of the factors tes-
ted with PFN1 inclusions. Additionally, while TDP-43 aggregates
are cross-seeded by PFN116,41, we observed mislocalization of
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nucleoporins and Ran even in the absence of PFN1 inclusions,
suggesting that TDP-43 mislocalization is a consequence rather
than the cause of NCT disturbance. Finally, we excluded from our
analyses any of the rare cells with spontaneous stress granule-like
formation due to PFN1 overexpression42, thus eliminating the
possibility that stress granules would induce NCT defects in our
experimental system14.
A more likely scenario is that mutant PFN1-dependent dis-
ruption of the actin cytoskeleton destabilizes the nuclear
membrane, leading to NCT defects. This is supported by the
observation that actin depolymerization caused by Latrunculin
A was sufficient to cause severe changes in the cellular
distribution of Ran, FG-Nups, and RanGAP1. Consistently, our
data suggest that excessive actin polymerization is also detri-
mental to the NPC function. Indeed, PFN1WT overexpression
by itself caused minor defects to the staining profile of Lamin
A/C and reduced nuclear import rates compared to GFP-
transfected controls. Further induction of actin polymerization
via mDia1 activation in PFN1WT cells also worsen many of the
observed phenotypes, leading to NPC structural and functional
changes. Restoring normal actin homeostasis in mutant
PFN1 cells, by genetic or pharmacological induction of mDia1
function was able to structurally and functionally rescue the
NPC. Intriguingly, we found that formin-dependent rescue was
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not limited to mutant PFN1 cells, but extended to cells
expressing the C9ORF72 repeat expansion, the most common
mutation found in ALS and FTD patients, in which NPC
defects have been largely reported2,3,6. Although the mechan-
isms driving this rescue are not fully understood yet, we spec-
ulate that actin may modulate the integrity of the NE via the
function of the linker of nucleoskeleton and cytoskeleton
(LINC) complex43, a multiprotein complex that physically
connects lamins with actin and microtubules. Of note, muta-
tions in LINC components cause cerebellar ataxia44,45, sug-
gesting that this complex plays an important role in the
maintenance of neuronal function and survival, possibly
through the modulation of NPC function. A similar pathogenic
mechanism has been recently suggested for tau-dependent
neurodegeneration, where altered microtubule polymerization
led to increased nuclear invaginations and NCT defects46–48.
Future work will be required to reveal how changes to actin
and, more generally, cytoskeleton homeostasis affect the LINC
complex and its functional consequences on the NCT and how
this pathway could be employed as a strategy to modulate NCT
function.
It remains an open question whether the NCT defects observed
in our model and others are a cause or a mere effect of the
degenerative process. Our data argue for the NPC dysfunction
being a primary driving force of ALS-associated cell toxicity.
Indeed, we found that pharmacological inhibition of nuclear
export rescued PFN1-dependent cellular defects, such as stunted
axon growth. Together with previous observation connecting
deficiencies in NCT to axonal guidance defects in flies49, our data
are particularly interesting as they functionally link the cytoske-
leton with NCT and mRNA post-transcriptional regulation. Axon
growth is a complex process that requires active cytoskeletal
growth50, fueled by the increased expression, transport, and local
translation of several cytoskeletal-related mRNAs51,52. Defects in
the localization and local translation of mRNAs at the tip of
axons and dendrites has been described in other neurological
diseases, such as SMA and Fragile X syndrome53,54, supporting
the relevance of these defects in disease pathogenesis. Our data
suggest that PFN1-dependent impairment of NCT and con-
sequent mislocalization/loss of function of nuclear RBPs leads to
impaired mRNA regulation, of which POLDIP3 pre-mRNA
splicing and Nefl mRNA axonal localization are two examples.
Rescue of the NPC function via modulation of the actin cytos-
keleton also leads to rescue in the Nefl mRNA localization to the
axon, which support our hypothesis that PFN1-mediated and
actin-dependent disruption of NCT may have severe downstream
consequences on general mRNA regulation, leading to a vicious
cycle that eventually leads to MN degeneration. Rescue in either
of these pathways would positively impact the others possibly
preserving MNs in ALS.
In conclusion, our results suggest a model whereby modula-
tions to actin dynamics can affect the stability and function of the
nuclear pore, adding cytoskeletal function to the list of mod-
ulators of NCT, together with protein aggregation and oxidative
stress1,14. The defects in NCT observed in ALS MNs could be
particularly relevant to disease pathogenesis as it may compro-
mise many cellular pathways relying on the integration between
signaling and changes in gene expression and/or RNA processing,
such as neurotrophic factors signaling or oxidative stress55–57.
Failure to integrate these signaling cascades would decrease the
cell’s ability to respond to environmental challenges, leading to
the accumulation of toxic insults. Regulating nuclear export or
restoring NPC function via modulation of the cytoskeleton-
nucleus connection could represent feasible therapeutic strategies
for multiple forms of ALS and other neurodegenerative diseases
beyond ALS.
Methods
Primary motor neuron culture, transfection, and treatments. Primary motor
neurons (MNs) were isolated from E12.5 mouse embryonic spinal cords dissociated
in 0.1% trypsin (Worthington) at 37 °C for 12 min. MNs were purified using a 6%
Optiprep (Sigma-Aldrich) density gradient and plated on glass coverslips coated
with 0.5 g/L poly-ornithine (Sigma-Aldrich) and laminin (Thermo Fisher). Cells
were grown at 37 °C and 5% CO2 in Neurobasal medium (Thermo Fisher) sup-
plemented with 0.25% Glutamax, 2% B27, 2% horse serum, and 10 ng/ml BDNF,
GDNF, and CNTF. MNs at 2 days in vitro (DIV) were transfected using 1.75 µl
NeuroMag reagent (OZ Biosciences)+ 0.5 µg DNA. Complete growth medium was
replaced with serum-free neurobasal medium 1 h prior and after transfection. The
paramagnetic nanobeads used for transfection can linger inside the cell and in
the extracellular space for several days and can be detected as DAPI positive dots.
The V5-PFN1 plasmids were described in Wu et al. (2011), while the (G4C2)80
construct was described in ref. 37. For the GFP-PFN1 constructs, WT or mutant
PFN1 was PCR amplified from the V5 constructs and cloned in the pEGFP-C1
backbone using BamHI sites. The FH1-FH2 domains of murine mDia1 (aa
553–1192) were PCR amplified using specific primers and cloned into the pEGFP-
C1 plasmid using XhoI and BamHI restriction sites. GFP or GFP-mDia1 were co-
transfected in a 1:2 ratio with PFN1 or C9ORF72 plasmids. Mock transfection
controls were performed by subjecting the cells to all the steps of transfection
without adding any plasmid DNA. For actin depolymerization assays, 2DIV MNs
were treated with 0.1 mg/L Latrunculin A (Cayman) for 3 days. For nuclear export
inhibition, MNs were treated with 50 nM KPT-276 (Selleck) or equal volume of
DMSO (Sigma Aldrich) 1 day after transfection. For formin induction, MNs were
treated with 0.1 µM IMM01 (EMD Millipore) for 24 h before fixation at 6DIV.
Lymphoblast cells culture. Immortalized lymphoblastoid cell lines obtained from
3 ALS patients carrying PFN1 mutations and 4 controls16 were cultured in RPMI
medium supplemented with 15% fetal bovine serum (FBS) for a maximum of 10
passages. Cells were seeded on a poly-ornithin coated coverslip at the density of
300 cell/mm2. Thirty minutes after plating, cells were fixed in 4% paraformalde-
hyde and processed for immunofluorescence assays as described below.
Cortical neuron culture, transfection, and treatments. Primary cortical neurons
were isolated from E15 mouse embryos dissociated in 0.05% trypsin-EDTA
(Thermo Scientific) at 37 °C for 12 min. 320,000 cells/ml were plated on poly-D-
lysine (0.125 mg/ml, Sigma Aldrich) and lamin (5 µg/ml, Corning) coated 96-well
glass plates and grown at 37 °C and 5% CO2 in Neurobasal medium (Thermo
Fisher) supplemented with 2% B27 and 1% Glutamax (Thermo Scientific). Four
DIV neurons were transfected with 0.2 µl Lipofectamine 2000 (Thermo Scientific)
and 100 ng DNA following manufacturer’s recommendations. A ratio of 4:1 was
used for the GFP and S-mCherry vectors. Thirsty-six hours after transfection,
Leptomycin B (10 mg/L) was added to the culture medium immediately before
image acquisition. Cells were imaged using a Nikon TiE widefield microscope
equipped with temperature- and CO2-controlled environmental chamber. Movies
were acquired with a ×20 lens at a rate of 1 frame every 1 or 2 min for 1 h. For
rescue experiments, neurons were fixed immediately after acquisition and stained
with V5 antibody to detect V5-PFN1 expression.
Fibroblast culture, treatment, and immunofluorescence. Fibroblasts were
obtained from skin biopsies of 3 ALS patients carrying mutations in C9ORF72 gene
and of 3 healthy donors, sex- and age-matched with ALS cases, after informed
consent and approval by the IRCCS Istituto Auxologico Italiano ethics committee.
C9ORF72 mutation was validated in primary fibroblasts by repeat-primed PCR
as previously described58 and repeat expansion size determined by Southern
blot analysis (range 600–1500 units). Fibroblasts were grown in RPMI 1640
medium (EuroClone) containing 2 g/l glucose and supplemented with 10% FBS
(Sigma Aldrich), 2 mM L-glutamine, 2,5 μg/ml amphotericin B (Sigma Aldrich),
100 units/ml penicillin and 100 μg/ml streptomycin (Gibco). 10.000 cell/well were
seeded on glass coverslip in 24-well plates and after 24 h, 50% of medium was
replaced with fresh medium and IMM01 (Sigma Aldrich) at the final concentration
of 0.1 µM. After 24-h treatment, cells were fixed with 4% paraformaldehyde for
20 min, permeabilized with 0.3% Triton X-100/1× PBS for 5 min and processed for
immunofluorescence as described below.
Immunofluorescence and image acquisition. Cells were fixed with 4% paraf-
ormaldehyde for 15 min. Fixed motor neurons were treated with hot 10 mM citrate
buffer, pH 6 for 20 min before permeabilization with 0.2% Triton-X 100 for 5 min.
Cells were blocked with 5% bovine serum albumin for 45 min and hybridized with
the appropriate antibodies overnight at 4 °C. Anti-mouse and anti-rabbit donkey
secondary antibodies or phalloidin conjugated with either Alexa Fluor 647, Alexa
Fluor 594, Alexa Fluor 555, Alexa Fluor 546, or Alexa Fluor 488 (Jackson
Immunoresearch and Thermo Fisher) were hybridized for 1 h at room tempera-
ture. Coverslips were mounted onto a glass slide using Prolong Gold mounting
medium (Thermo Fisher) or FluorSave mounting medium (Calbiochem) and
imaged using an epifluorescence microscope (Nikon Ti E) equipped with a cooled
CMOS camera (Andor Zyla) or a Digital sight DS-U3 camera. Images were
acquired as Z-stacks (0.2 µm step size) using a ×60 lens unless otherwise specified.
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For propidium iodide (PI) staining, cells were incubated with 20 µg/ml PI (Thermo
Fisher) for 30 min at 37 °C before fixation. As a positive control, cells were heat
shocked at 65 °C for 30 min before incubation with PI.
Transmission electron microscopy. Six-well plates of cultured cells were fixed
overnight at 4 °C by adding 1 ml of 2.5% glutaraldehyde in 0.1 M Na cacodylate-
HCl buffer (pH 7.2). Fixed samples were washed three times in 0.5 M Na
cacodylate-HCl buffer (pH 7.0) and post-fixed for 1 h in 1% osmium tetroxide (w/v)
in the same buffer at room temperature. Following post-fixation, the culture dish
with adherent cells were enblock stained (20 min) with 1% aqueous uranyl-acetate
(w/v). The fixed cell culture dishes were washed again in the same buffer and
dehydrated through a graded series of ethanol to 100% and transferred through
two changes of 50/50 (v/v) SPIpon resin (Structure Probe, Inc.)/100% ethanol and
left overnight to infiltrate. The following morning the cell culture plates were
transferred through three changes of fresh SPIpon resin to finish the infiltration
and embedding and finally, the dishes were filled with freshly prepared SPIpon
resin and polymerized for 48 h at 70 °C. Once fully polymerized, the six-well-plate
was cut apart and each well was plunged into liquid nitrogen to separate the
SPIpon epoxy block with the embedded cells from the culture dish. The round
epoxy disks with the embedded cells were then examined under an upright light
microscope and areas of cells were cut from the disks and glued onto blank
microtome studs and trimmed for ultramicrotomy. Ultrathin sections (70 nm)
were cut on a Reichart-Jung ultramicrotome using a diamond knife. The sections
were collected and mounted on copper support grids and contrasted with lead
citrate and uranyl acetate and examined on a FEI Tecnai G2 Spirit transmission
electron microscope at 100 Kv accelerating voltage and images were recorded at
various magnifications using a Gatan 2 K digital camera system.
Fluorescence in situ hybridization. Motor neurons were fixed in 4% RNase-free
paraformaldehyde for 15 minutes and stored in 70% ethanol at 4 °C overnight.
Cells were sequentially incubated for 5 min in 1× PBS and wash buffer (2× SSC,
10% formamide), and hybridized in hybridization buffer (10 mg/ml dextran sulfate,
4 mg/ml BSA, 40 µM ribonucleoside vanadyl complexes, 2× SSC, 1% PBS) at 37 °C
overnight with 12.5 µM probes and 0.2 mg/ml each salmon sperm DNA and E. Coli
tRNA. Neurofilament L mRNA specific probes were design using Biosearch
Technology online tool and conjugated with the Quasar® 570 fluorophore (Table
S2). Coverslips were then washed twice for 30 min at 37 °C in wash buffer before
mounting them as described above. FISH for C9ORF72 sense RNA hexanucleotide
repeat was performed using the LNA probe 5’TYE563/CCCCGGCCCCGGCCCC
(Exiqon) as described in Chew et al.59.
Axon length and outgrowth analysis. Motor neurons were co-transfected as
outlined above with green fluorescent protein (GFP) and V5-tagged PFN1 con-
structs in a 1:2 ratio. KPT-276 (50 nM) or equal volumes of DMSO were added to
the culture medium 1 day after transfection and maintained throughout the
experiment for a total of 3 days. Cells were fixed and stained to detect V5-PFN1
expression 4 days after transfection. Cells were imaged as individual focal planes
using a ×10 lens. GFP was used to identify transfected cells and highlight the whole
cell structure. For live imaging of axon outgrowth, KPT-276 (50 nM) or equal
volumes of DMSO were added to the culture medium 1 day after transfection and
maintained throughout the experiment for a total of ~18–24 h. Cells were imaged
at 3 DIV using a Nikon TiE widefield microscope equipped with temperature- and
CO2-controlled environmental chamber. Movies were acquired with a ×20 lens at a
rate of 1 frame every 10 min for 1 h.
Immunoprecipitations, solubility assays, and western blots. HEK293 cells
grown in DMEM+ 10% FBS were transfected with V5-PFN1 constructs and lysed
with lysis buffer (20 mM Tris, 150 mM NaCl, 1% Triton X-100, protease inhibitor
Complete EDTA-free, Roche) 24 or 48 h after transfection. For immunoprecipi-
tations, the detergent-soluble lysates were added to 30 µL of Protein A-Agarose
beads (Roche) and 0.3 µg of anti-V5 antibody (Novus) and rocked overnight at 4 °C.
Immunoprecipitated complexes were eluted in Laemmli buffer (60 mM Tris-Cl pH
6.8, 2% SDS, 10% glycerol, 5% beta-mercaptoethanol, 0.01% bromophenol blue)
and then subjected to western blot analysis. For solubility assays, lysates were
sonicated on ice and then centrifuged at 16,000 × g for 10 min at 4 °C. The
supernatant was collected as the soluble fraction. The pellet was washed three times
with lysis buffer, resuspended in 8M urea, sonicated, and then centrifuged at
16,000 × g for 10 min at 4 °C. The supernatant was collected as the insoluble
fraction.
Samples were resolved by SDS-PAGE on Mini Protean TGX 4–20% gradient
polyacrylamide gels (Bio-Rad) and transferred onto nitrocellulose membranes
(Bio-Rad). Membranes were blocked with Odyssey Blocking Buffer (LI-COR) and
probed with primary antibodies overnight. Secondary antibodies conjugated with
IRDye® infrared fluorophores (LI-COR) were incubated for 1 h at room
temperature. Blots were visualized using the Odyssey Infrared Imaging System (LI-
COR). Uncropped scans of the blots are shown in Supplementary Fig. 15.
POLDIP3 splicing assay. Whole RNA was extracted from 5 × 106 lymphoblast
cells using TriZol reagent (Thermo Fisher) according to the manufacturer’s
instructions. RNA (2 µg) was retrotranscribed using the High-Capacity cDNA
Reverse Transcription Kit (Thermo Fisher). RT-PCR was performed using specific
primers amplifying exon2-exon4 of human POLDIP3 mRNA. DNA gels were
stained with SYBR Safe dye (Thermo Fisher) and imaged using the ChemiDoc XR+
imager (BioRad).
Image processing and quantification. Immunofluorescence images were decon-
volved using an adaptative blind deconvolution algorithm (Autoquant X3, Media
Cybernetics) before analysis. To measure fluorescence intensities, the signals were
thresholded and the resulting integrated densities were normalized on the area of
the selected region (e.g., cell body, nucleus). Thresholds were kept consistent for all
images within experiments. For all experiments, values were normalized to
PFN1WT averages so that PFN1WT always= 1 ± SEM. For NCT dynamics, the
fluorescence intensity of S-mCherry was measured in the nucleus using ImageJ and
normalized to the background for every time point. All values were subsequently
normalized to T0. For the analysis of axonal fluorescence intensities, a 100 µm long
region of the proximal axon was measured in all conditions. Axon lengths were
measured using the ImageJ plugin NeuronJ60. The axon was defined as the longest
neurite. The rate of axon outgrowth was measured using the ImageJ plugin
MTrackJ by tracking the movement of the growth cone in all fields61,62. A blinded
analysis was performed to assess RanGAP1, RanBP2, POM121, F-Nups, and Lamin
A/C localization on 3D stacks of individual optical slices. To avoid mis-
interpretation of staining profiles, no 3D to 2D compression of the images was
performed as suggested63,64. For nucleoporin analysis, abnormal staining was
considered if the signal was not uniformly distributed around the nucleus with the
presence of empty bare segments. For Lamin A/C, abnormal staining was defined
as the absence of a think and uniform layer around the nucleus. DAPI was used as
a reference for nuclear boundary. For all experiments, raw values were normalized
to the mean of the control condition.
Nuclear dextran assay. Nuclei were isolated from lymphoblasts and then incu-
bated with fluorescently labeled-Dextrans as described with minor
modifications65,66. Briefly, 106 cells were pelleted by centrifugation for 5 min at
4 °C at 2600 RPM and resuspended in 1 mL of sucrose buffer (0.32 M sucrose, 3
mM CaCl2, 2 mM magnesium acetate, 0.1 mM EDTA, 10 mM Tris HCl, 1 mM
dithiothreitol, and protease inhibitors (Roche, cat # 11873580001)) with 1% NP-40.
After 20 min incubation on ice, the cells were washed in sucrose buffer and
centrifuged for 5 min at 2600 RPM at 4 °C. The pellet was washed in 1 mL of TR
buffer (20 mM HEPES, 110 mM KOAc, 2 mM Mg(OAc)2, 5 mM NaOAc, 0.5 mM
EGTA, 250 mM sucrose, and protease inhibitors) and the isolated nuclei were then
incubated for 30 min in 100 uL of TRB containing 0.6 mg/mL of 70 KDa RITC-
Dextran (Millipore Sigma, R9379), 0.6 mg/mL of 500 KDa FITC-Dextran (Milli-
pore Sigma, 46947), and Dapi and imaged using confocal microscopy (A1R,
Nikon). Images were analyzed using image J. RITC-dextran intensity in the nucleus
was defined as the ratio of the nuclear mean intensity to the background intensity.
Nuclei in which the RITC-dextran intensity was greater than the mean RITC-
dextran intensity of all control nuclei plus 2 standard deviations were classified as
leaky nuclei.
Statistical analysis. Statistical analyses were performed using Prism 8 software
package (GraphPad). Normality of the samples was assessed using the D’Agostino
& Pearson Omnibus test. According to normality, parametric or non-parametric
tests were used to assess significance, defined as p < 0.05. For nuclear import assays,
the slope was calculated on the curve averages as shown in the graphs. Detailed
information on all statistical tests performed is listed in Table S1.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated during the current study are available from the corresponding
author on reasonable request.
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